King International Investment Past Earnings Performance
Past criteria checks 2/6
King International Investment has been growing earnings at an average annual rate of 39.3%, while the Healthcare industry saw earnings growing at 6.9% annually. Revenues have been growing at an average rate of 30.6% per year. King International Investment's return on equity is 5.7%, and it has net margins of 6.8%.
Key information
39.3%
Earnings growth rate
47.0%
EPS growth rate
| Healthcare Industry Growth | 11.3% |
| Revenue growth rate | 30.6% |
| Return on equity | 5.7% |
| Net Margin | 6.8% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Recent updates
King International Investment's (HKG:928) Performance Raises Some Questions
Aug 07
King International Investment Limited (HKG:928) Might Not Be As Mispriced As It Looks After Plunging 26%
Dec 21Benign Growth For Life Healthcare Group Limited (HKG:928) Underpins Stock's 43% Plummet
Jul 13Life Healthcare Group (HKG:928) Is Looking To Continue Growing Its Returns On Capital
Oct 28Revenue & Expenses Breakdown
How King International Investment makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 234 | 16 | 20 | 0 |
| 31 Dec 23 | 242 | -3 | 33 | 0 |
| 30 Sep 23 | 251 | -22 | 46 | 0 |
| 30 Jun 23 | 237 | -24 | 45 | 0 |
| 31 Mar 23 | 224 | -25 | 45 | 0 |
| 31 Dec 22 | 143 | -28 | 44 | 0 |
| 30 Sep 22 | 62 | -31 | 43 | 0 |
| 30 Jun 22 | 77 | -33 | 44 | 0 |
| 31 Mar 22 | 93 | -34 | 45 | 0 |
| 31 Dec 21 | 95 | -22 | 36 | 0 |
| 30 Sep 21 | 98 | -10 | 27 | 0 |
| 30 Jun 21 | 100 | -7 | 26 | 0 |
| 31 Mar 21 | 102 | -5 | 26 | 0 |
| 31 Dec 20 | 125 | -8 | 25 | 0 |
| 30 Sep 20 | 149 | -12 | 25 | 0 |
| 30 Jun 20 | 106 | -18 | 29 | 0 |
| 31 Mar 20 | 64 | -25 | 32 | 0 |
| 31 Dec 19 | 45 | -43 | 70 | 0 |
| 30 Sep 19 | 26 | -62 | 109 | 0 |
| 30 Jun 19 | 45 | -90 | 137 | 0 |
| 31 Mar 19 | 63 | -117 | 164 | 0 |
| 31 Dec 18 | 72 | -118 | 151 | 0 |
| 30 Sep 18 | 81 | -118 | 138 | 0 |
| 30 Jun 18 | 72 | -104 | 128 | 0 |
| 31 Mar 18 | 63 | -91 | 117 | 0 |
| 30 Sep 17 | 45 | -59 | 72 | 0 |
| 30 Jun 17 | 36 | -47 | 55 | 0 |
| 31 Mar 17 | 27 | -34 | 39 | 0 |
| 31 Dec 16 | 18 | -33 | 42 | 0 |
| 30 Sep 16 | 8 | -28 | 39 | 0 |
| 30 Jun 16 | 7 | -31 | 41 | 0 |
| 31 Mar 16 | 5 | -34 | 42 | 0 |
| 31 Dec 15 | 7 | -37 | 36 | 0 |
| 30 Sep 15 | 8 | -39 | 30 | 0 |
| 30 Jun 15 | 8 | -42 | 29 | 0 |
| 31 Mar 15 | 8 | -45 | 29 | 0 |
| 31 Dec 14 | 13 | -42 | 51 | 0 |
| 30 Sep 14 | 17 | -38 | 74 | 0 |
| 30 Jun 14 | 20 | -54 | 90 | 0 |
| 31 Mar 14 | 22 | -71 | 106 | 0 |
| 30 Sep 13 | 21 | -113 | 100 | 0 |
Quality Earnings: 928 has a large one-off gain of HK$5.5M impacting its last 12 months of financial results to 31st March, 2024.
Growing Profit Margin: 928 became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 928 has become profitable over the past 5 years, growing earnings by 39.3% per year.
Accelerating Growth: 928 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: 928 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare industry (3.1%).
Return on Equity
High ROE: 928's Return on Equity (5.7%) is considered low.